Shinnosuke Takemoto
Papers
1
Total Citations
2
H-Index
1
About
Shinnosuke Takemoto is a leading authority in thoracic oncology, with a focused expertise in thymic epithelial tumors and lung cancer management. His major contribution lies in shaping evidence-based clinical practice through his pivotal role in the Japan Lung Cancer Society’s Medical Practice Guidelines. As a key editor and author of the 2024 guidelines, Takemoto synthesized complex data to produce clear, actionable recommendations for thymic tumors, malignant pleural mesotheliomas, and lung cancers—directly influencing treatment standards across Japan. His most cited work, the 2025 summary of recommendations for thymic epithelial tumors (2 citations), serves as a cornerstone for clinicians navigating rare thoracic malignancies. Beyond guideline development, Takemoto’s research bridges the gap between rigorous evidence and real-world application, ensuring that patients benefit from the latest therapeutic advances. His dedication to standardizing care for challenging cancers underscores his impact as a clinician-scholar, making him an essential resource for students and researchers seeking authoritative, practice-changing insights in thoracic oncology.
Research Focus
Key Achievements
Top Papers
- 1